NCT06878885

Brief Summary

Volunteers for the study are asked to participate in two laboratory sessions. In the first laboratory session, volunteers are asked to provide a blood sample which will be used to measure factors related to health. Participants also complete questionnaires related to demographic and health-related information and undergo evaluations of their body composition. In the second laboratory visit, participants are asked to have cardiovascular, neuroendocrine, and inflammatory activity measured during a brief period of rest and during a short challenging psychological task. Participants will also complete questionnaires. The study is designed to examine the associations between experiences such as trauma and resiliency with changes in bodily systems during a challenge and current health.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
14mo left

Started May 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress64%
May 2024Jun 2027

Study Start

First participant enrolled

May 10, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

January 10, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 17, 2025

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2027

Last Updated

March 17, 2025

Status Verified

March 1, 2025

Enrollment Period

3.1 years

First QC Date

January 10, 2025

Last Update Submit

March 10, 2025

Conditions

Outcome Measures

Primary Outcomes (23)

  • Changes in systolic blood pressure activity from baseline to task

    The mean systolic blood pressure (mmHg) will be subtracted from the mean of the task period.

    10 minute resting baseline mean will be subtracted from the 4 minute task period for each value

  • Changes in diastolic blood pressure activity from baseline to task

    The mean diastolic blood pressure (mmHg) will be subtracted from the mean of the task period.

    10 minute resting baseline mean will be subtracted from the 4 minute task period for each value

  • Changes in heart rate activity from baseline to task

    The mean heart rate (bpm) will be subtracted from the mean of the task period.

    10 minute resting baseline mean will be subtracted from the 4 minute task period for each value

  • Change in cortisol from baseline to task

    Salivary samples will be taken to measure cortisol (nmol/L) the mean from the peak stress period will be subtracted from the baseline

    Baseline will be subtracted from the peak (15 minutes after task onset, 35 minute task onset)

  • Changes in IL-6 from baseline to task

    IL-6 (pg/mL) measured at baseline will be subtracted from the IL-6 measured post task.

    Baseline will be subtracted from the level 30 minutes after task onset.

  • Pulse wave velocity

    Pulse wave velocity in m/s will be assessed by dual impedance cardiography as a non-invasive indicator of arterial stiffness. This measure will be derived from the 5 minute baseline period.

    5 minutes

  • Resting systolic blood pressure

    Resting systolic blood pressure (mmHg)

    10 minutes

  • Resting diastolic blood pressure

    Resting diastolic blood pressure (mmHg)

    10 minutes

  • Inflammatory and anti-inflammatory cytokines

    Circulating levels of C-reactive protein, interleukin-6, tumor necrosis factor-a, monocyte chemoattractant protein-1, interleukin-1b, interleukin-10, and adiponectin will be assessed via a blood draw. A composite score will be created.

    5 minutes

  • Hemoglobin A1c

    Hemoglobin A1c (nmol/L) will be assessed via blood draw

    5 minutes

  • Glucose

    Glucose (nmol/L) will be assessed via blood draw

    5 minutes

  • Insulin

    Insulin (mL) will be assessed via blood draw

    5 minutes

  • Cholesterol

    Total cholesterol (mg) will be assessed via blood draw

    5 minutes

  • Low-density lipoprotein

    Low-density lipoprotein (mg/dL) will be assessed via blood draw

    5 minutes

  • High-density lipoprotein

    high-density lipoprotein (mg/dL) will be assessed via blood draw

    5 minutes

  • Triglycerides

    Triglycerides (mmol/L) will be assessed via blood draw

    5 minutes

  • Waist circumference

    Waist circumference

    2 minutes

  • Hip circumference

    Hip circumference

    2 minutes

  • Depressive symptomology (Hospital Anxiety Depression Questionnaire depression subscale)

    Hospital Anxiety Depression Questionnaire (depression subscale)

    10 minutes

  • Depressive symptomology (PHQ-9)

    PHQ-9

    10 minutes

  • Anxiety symptomtology

    Hospital Anxiety Depression Questionnaire (Anxiety subscale)

    5 minutes

  • Alcohol use

    Alcohol use will be assessed using the Alcohol Use Identification Test

    10 minutes

  • Substance use

    A cumulative score of substance use will be reported by indicating the number of recreational drugs "ever" tried

    5 minutes

Study Arms (1)

Paced Auditory Serial Addition Task

EXPERIMENTAL

Volunteers are presented with an audio playing of single digit numbers between 1 and 9. They are instructed to add the number with the number previously presented and say the answer out loud. Volunteers are told their performance is being scored by research assistants. Volunteers are also instructed to look at themselves in a mirror while partaking in the task. Volunteers are informed they can discontinue at any time. Volunteers complete brief questionnaires before and after the task to asses their perceptions of stress, arousal, and anxiety.

Behavioral: Acute psychological stress task (Paced Auditory Serial Addition Task)

Interventions

Volunteers will complete a 4-minute Paced Auditory Serial Addition Task which is a standardized laboratory challenge that is widely used to monitor cardiovascular, neuroendocrine, and inflammatory responses in the laboratory.

Paced Auditory Serial Addition Task

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years
  • Identifying as American Indian
  • Living on or near Blackfeet reservation

You may not qualify if:

  • Uncontrolled hypertension

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Blackfeet Community College

Browning, Montana, 59417, United States

RECRUITING

MeSH Terms

Conditions

Stress, PsychologicalPsychological Well-Being

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorPersonal Satisfaction

Study Officials

  • Neha John-Henderson, PhD

    Montana State University

    PRINCIPAL INVESTIGATOR
  • Annie Ginty, PhD

    Baylor University

    PRINCIPAL INVESTIGATOR
  • Betty Henderson-Mathews, MA

    Blackfeet Community College

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Neha John-Henderson, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: The study is designed to examine cardiovascular, neuroendocrine, and inflammatory responses to a brief (4 minutes) mental arithmetic task (i.e., a psychological challenge) in the laboratory. Cardiovascular activity will be measured during a resting baseline period (10 minutes) and during the task (4 minutes). Participants will provide salivary samples before the task and after the task (\~20-90 minutes) which will be used to assess neuroendocrine (i.e., cortisol) and inflammatory (i.e., IL-6). Cardiovascular, neuroendocrine, and inflammatory responses will be examined in relation to other study outcomes.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 10, 2025

First Posted

March 17, 2025

Study Start

May 10, 2024

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

June 30, 2027

Last Updated

March 17, 2025

Record last verified: 2025-03

Locations